QUOIN PHARMACEUTICALS LT-ADR (QNRX) Stock Income Statement
NASDAQ:QNRX - Nasdaq - US74907L3006 - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 9.53M | 9.38M | 9.26M | 6.06M | 4.07M | |||
| Research and Development | 3.60M | 3.31M | 2.67M | 1.56M | 1.71M | |||
| Selling, General, and Administrative Expenses | 5.93M | 6.07M | 6.58M | 4.50M | 2.36M | |||
| Operating Income | -9.53M | -9.38M | -9.26M | -6.06M | -4.07M | |||
| Interest Income/Expense | 566.00K | 691.90K | -620.00K | -1.37M | 0.00 | |||
| Other Income/Expense | N/A | 0.00 | 80.00K | -14.03M | -1.19M | |||
| Non Recurring Items | N/A | 0.00 | 420.00K | N/A | N/A | |||
| Income Before Taxes | -8.96M | -8.69M | -9.38M | -21.46M | -5.26M | |||
| Income Tax | N/A | N/A | N/A | 0.00 | N/A | |||
| Net Income | -8.96M | -8.69M | -9.45M | -21.46M | -5.26M | |||
| EBITDA | -9.43M | -9.27M | -9.16M | -5.96M | -3.86M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.61 | -3.06 | 0.00 | -0.05 | -0.05 | |||
| Non GAAP EPS | -30.20 | -10.24 | -85.08 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD